Microbot Medical-B (02252): Total Global Commercial Orders of Tumai Surpass 300 Units.

Zhitong Financial News APP, MicroPort Robotics - B (02252) announced that as of the date of this announcement, the total number of comprehensive orders for the group's core products including laparoscopy, orthopedics, and vascular intervention has accumulated to nearly 400 units. Among them, the group's core product, the TIANJI laparoscopic surgical robot (Tianji), has surpassed 300 units in global commercial orders, with new orders in the first half of the year exceeding the total for the entire previous year. This milestone achievement in Tianji's commercial orders once again demonstrates its competitive product strength, brand recognition, and mature overseas channel layout capabilities, signaling rapid business expansion. Looking back on Tianji's commercial journey, the first hundred orders went through nearly 1,000 days of product refinement and market cultivation, while the third hundred orders took only over 120 days, fully confirming Tianji's overall mature competitive strength, brand recognition, and overseas channel layout capabilities, and business expansion is now entering the fast lane.